In recent years, the term regenerative medicine has entered common language. It is an evocative expression, but often misunderstood, as it suggests the idea of rebuilding what has been damaged. In reality, its meaning is more precise and, in some respects, more interesting: regenerative medicine is an approach aimed at stimulating and modulating the body’s natural repair mechanisms by acting on the biological environment of the affected tissue. It does not replace surgery when necessary, nor does it eliminate the need for rehabilitation. Rather, it creates more favorable conditions for the body to respond more effectively to treatment.
PRP (Platelet-Rich Plasma) is one of the most well-known tools in this field. It is not a chemical drug, nor is it a substance foreign to the body. It is a concentrate derived from the patient’s own blood, designed to locally enhance some of the self-repair capacities that the body already possesses.
What Is PRP and How Does It Work
PRP is obtained from the patient’s own blood. A standard venous blood draw is performed and then subjected to centrifugation. This process separates the different blood components and makes it possible to isolate a plasma fraction with a platelet concentration higher than physiological levels.
Platelets are not merely “clotting cells.” They contain granules rich in growth factors and biologically active molecules involved in the processes of inflammation, angiogenesis, and tissue remodeling.
When PRP is injected into a specific area, these molecules are released locally and may help to:
- modulate chronic inflammation
- promote neoangiogenesis
- stimulate local cellular activity
- improve the biological environment of the affected tissue
It is important to understand that this does not mean “rebuilding” a degenerated tissue. In the case of osteoarthritis, for example, PRP does not fully regenerate cartilage. Rather, it may improve the joint microenvironment and contribute to a better balance between degeneration and reparative response, with clinical effects in terms of pain and function.
In this sense, regenerative medicine works on the biological context, not just on the symptom.
Main Indications
The strongest scientific evidence concerns knee osteoarthritis in its early and intermediate stages. The most recent international consensus statements, including that of ESSKA–ICRS, consider PRP an appropriate option in selected patients with mild to moderate osteoarthritis who have not achieved sufficient benefit from conservative treatments such as therapeutic exercise and load management.
In these cases, PRP may help reduce pain, improve joint function, and increase tolerance to physical activity.
Another important indication is chronic tendinopathies, particularly lateral epicondylitis and patellar tendinopathy, where some evidence suggests a medium-term clinical benefit. In these conditions, PRP may support a tendon that struggles to recover from a state of chronic dysfunction.
In muscle injuries, its use is more selective and the evidence is still evolving, but it may be considered in specific contexts, particularly in sports settings.
Expected Effects and Response Time
One of the key aspects is the proper management of expectations. PRP does not produce an immediate effect like an anesthetic or a corticosteroid. In the first few days, there may be a slight increase in pain or a sensation of local stiffness, related to the activation of the biological response.
When improvement occurs, it tends to appear gradually over the following weeks, with more noticeable benefits between one and three months. Expected effects include:
- reduction in pain
- improvement in function
- greater load-bearing capacity
- possible stabilization of symptoms in the early stages of degenerative conditions
The response varies from person to person and depends on the stage of the condition, overall health status, and integration with the rehabilitation program.
Safety, Contraindications, and Side Effects
PRP is an autologous treatment, so the risk of allergic reactions is very low. However, it is not indicated in the presence of active infections, significant hematological disorders, or uncontrolled coagulation disorders.
The most common side effects are local and temporary: pain at the injection site, mild swelling, and temporary limitation of movement. Significant complications are rare when the procedure is performed in an appropriate setting and under ultrasound guidance.
The Role of Ultrasound and the Integrated Approach
Precision is a central element. Musculoskeletal ultrasound makes it possible to accurately identify the structure involved and to guide the injection to the correct location. Evidence indicates that ultrasound-guided injections are more accurate than those performed based solely on anatomical landmarks.
However, the true effectiveness of PRP emerges when it is integrated into a pathway that includes a thorough clinical evaluation, functional assessment, and a personalized rehabilitation program. The biological treatment creates a favorable environment; rehabilitation builds functional recovery.
A Balanced Perspective
PRP represents one of the most concrete applications of regenerative medicine in the musculoskeletal field. It is neither a universal solution nor a miracle therapy, but a tool that can play a significant role in selected situations.
Its strength does not lie in the uniqueness of the procedure, but in the rationale with which it is integrated into a broader therapeutic plan. When used appropriately, in carefully evaluated patients and within a structured rehabilitation pathway, it can help improve pain, function, and quality of life.
Modern medicine does not seek shortcuts, but personalized strategies. It is within this balance between biology, movement, and clinical expertise that the most authentic meaning of regenerative medicine is found.
Essential References
- Filardo G, Di Matteo B, Di Martino A, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: ESSKA–ICRS consensus. Knee Surg Sports Traumatol Arthrosc. 2024.
- American Academy of Orthopaedic Surgeons. Technology Overview: Platelet-Rich Plasma for Knee Osteoarthritis. 2021.
- Andriolo L, Altamura SA, Reale D, et al. Nonsurgical treatments of patellar tendinopathy: ESSKA consensus. J Exp Orthop. 2018;5:15.
- Papalia R, et al. Ultrasound-guided versus landmark-guided injections in musculoskeletal disorders: systematic review and meta-analysis. 2024.
- Kon E, Di Matteo B, Delgado D, et al. Platelet-rich plasma: indications and consensus recommendations. Knee Surg Sports Traumatol Arthrosc. 2025.
